JP2022539089A5 - - Google Patents

Info

Publication number
JP2022539089A5
JP2022539089A5 JP2021577003A JP2021577003A JP2022539089A5 JP 2022539089 A5 JP2022539089 A5 JP 2022539089A5 JP 2021577003 A JP2021577003 A JP 2021577003A JP 2021577003 A JP2021577003 A JP 2021577003A JP 2022539089 A5 JP2022539089 A5 JP 2022539089A5
Authority
JP
Japan
Prior art keywords
mol
alkyl
present
amount
alkyl groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021577003A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022539089A (ja
JP7420841B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2020/050897 external-priority patent/WO2021000041A1/en
Publication of JP2022539089A publication Critical patent/JP2022539089A/ja
Publication of JP2022539089A5 publication Critical patent/JP2022539089A5/ja
Priority to JP2024002304A priority Critical patent/JP7667327B2/ja
Application granted granted Critical
Publication of JP7420841B2 publication Critical patent/JP7420841B2/ja
Priority to JP2025065109A priority patent/JP7908452B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021577003A 2019-06-29 2020-06-26 核酸送達のためのイオン化可能な脂質 Active JP7420841B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2024002304A JP7667327B2 (ja) 2019-06-29 2024-01-11 核酸送達のためのイオン化可能な脂質
JP2025065109A JP7908452B2 (ja) 2019-06-29 2025-04-10 核酸送達のためのイオン化可能な脂質

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962868900P 2019-06-29 2019-06-29
US62/868,900 2019-06-29
US202063009042P 2020-04-13 2020-04-13
US63/009,042 2020-04-13
PCT/CA2020/050897 WO2021000041A1 (en) 2019-06-29 2020-06-26 Ionizable lipids for nucleic acid delivery

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024002304A Division JP7667327B2 (ja) 2019-06-29 2024-01-11 核酸送達のためのイオン化可能な脂質

Publications (3)

Publication Number Publication Date
JP2022539089A JP2022539089A (ja) 2022-09-07
JP2022539089A5 true JP2022539089A5 (enExample) 2023-07-04
JP7420841B2 JP7420841B2 (ja) 2024-01-23

Family

ID=74100092

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021577003A Active JP7420841B2 (ja) 2019-06-29 2020-06-26 核酸送達のためのイオン化可能な脂質
JP2024002304A Active JP7667327B2 (ja) 2019-06-29 2024-01-11 核酸送達のためのイオン化可能な脂質

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024002304A Active JP7667327B2 (ja) 2019-06-29 2024-01-11 核酸送達のためのイオン化可能な脂質

Country Status (7)

Country Link
US (1) US12636368B2 (enExample)
EP (1) EP3990441A4 (enExample)
JP (2) JP7420841B2 (enExample)
KR (2) KR102928289B1 (enExample)
CN (1) CN115279743B (enExample)
CA (1) CA3143578A1 (enExample)
WO (1) WO2021000041A1 (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3864163T3 (da) 2018-10-09 2024-05-06 Univ British Columbia Sammensætninger og systemer omfattende transfektionskompetente vesikler fri for organiske opløsningsmidler og rengøringsmidler og fremgangsmåder forbundet dermed
CN112888451A (zh) * 2018-10-19 2021-06-01 川斯勒佰尔公司 信使rna的无泵包封
CZ310613B6 (cs) * 2020-09-23 2026-01-28 Ústav organické chemie a biochemie AV ČR, v. v. i. Lipidoidy pro transfekci nukleových kyselin a jejich použití
CN117098541A (zh) 2020-11-25 2023-11-21 阿卡格拉医药公司 用于递送核酸的脂质纳米粒及相关使用方法
CN112961065B (zh) * 2021-02-05 2023-03-14 嘉晨西海(杭州)生物技术有限公司 一种可电离脂质分子及其制备方法及其在制备脂质纳米颗粒的应用
CN114149337B (zh) * 2021-07-07 2022-04-29 天津键凯科技有限公司 一种用于核酸递送的新型可电离脂质及其lnp组合物
JP7689238B2 (ja) 2021-07-27 2025-06-05 エスケー バイオサイエンス カンパニー リミテッド タンパク質発現のためのmRNA、及びそのためのテンプレート
WO2023044343A1 (en) 2021-09-14 2023-03-23 Renagade Therapeutics Management Inc. Acyclic lipids and methods of use thereof
TW202328067A (zh) 2021-09-14 2023-07-16 美商雷納嘉德醫療管理公司 環狀脂質及其使用方法
WO2023067121A1 (en) * 2021-10-22 2023-04-27 BioNTech SE Oligosaccharide compounds and complexes
JP2024543721A (ja) * 2021-10-22 2024-11-22 ビオンテック・ソシエタス・エウロパエア オリゴ糖複合体及び用途
US11510975B1 (en) 2021-11-29 2022-11-29 Replicate Bioscience, Inc. Compositions and methods for inducing ESR1, PI3K, HER2, and HER3 immune responses
CA3143650A1 (en) * 2021-12-22 2023-06-22 Providence Therapeutics Holdings Inc. Lipids and compositions thereof
WO2023230587A2 (en) 2022-05-25 2023-11-30 Akagera Medicines, Inc. Lipid nanoparticles for delivery of nucleic acids and methods of use thereof
WO2024006863A1 (en) 2022-06-30 2024-01-04 Precision NanoSystems ULC Lipid nanoparticle formulations for vaccines
AU2023393613A1 (en) 2022-12-12 2025-06-19 Global Life Sciences Solutions Canada Ulc Lipid nanoparticles lyophilization methods and compositions
IL321425A (en) 2022-12-23 2025-08-01 Biontech Delivery Tech Gmbh compound
EP4719352A1 (en) 2023-05-31 2026-04-08 Capstan Therapeutics, Inc. Lipid nanoparticle formulations and compositions
KR20260030139A (ko) 2023-06-28 2026-03-05 글로벌 라이프 사이언시즈 솔루션즈 캐나다 유엘씨 세포 요법을 위한 지질 나노입자 제형 및 관련 방법
IL326522A (en) 2023-08-21 2026-04-01 Global Life Sciences Solutions Canada Ulc Method and apparatus for ion flux lipid nanoparticle manufacture
WO2025049579A1 (en) 2023-08-31 2025-03-06 Global Life Sciences Solutions Canada Ulc Intranasal formulation for pulmonary delivery of nanoparticles, compositions, uses, and manufacturing methods thereof
CN119143714B (zh) * 2023-12-11 2025-06-10 仁景(苏州)生物科技有限公司 用于递送的脂质化合物和脂质纳米颗粒
WO2025219528A1 (en) 2024-04-17 2025-10-23 Global Life Sciences Solutions Canada Ulc Non-destructive plasmid delivery to immune cells
WO2025219491A1 (en) 2024-04-17 2025-10-23 Global Life Sciences Solutions Canada Ulc Method and composition for hdr template dna delivery
WO2025224267A1 (en) 2024-04-25 2025-10-30 Global Life Sciences Solutions Canada Ulc Method for producing a liquid composition including a nanoparticle, and formulation thereof
WO2026043843A1 (en) * 2024-08-19 2026-02-26 The Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Tetrahydropyrimidine (thp) ionizable lipids for efficient mrna delivery
WO2026052844A1 (en) 2024-09-09 2026-03-12 Global Life Sciences Solutions Canada Ulc 3-component lipid nanoparticle compositions, uses, and manufacturing methods thereof
WO2026052854A1 (en) 2024-09-09 2026-03-12 Global Life Sciences Solutions Canada Ulc 3-component lipid nanoparticle compositions, uses, and manufacturing methods thereof
WO2026109722A1 (en) 2024-11-21 2026-05-28 Aldexchem Kft. Advanced silicon-containing lipid nanoparticles for efficient human t cell transfection
WO2026122996A1 (en) * 2024-12-06 2026-06-11 Tessera Therapeutics, Inc. Lipid nanoparticles for delivery of therapeutic payloads to cells
WO2026146172A1 (en) 2024-12-31 2026-07-09 Global Life Sciences Solutions Canada Ulc Lipid nanoparticle formulations and methods of preparing thereof
WO2026149959A1 (en) 2025-01-08 2026-07-16 Global Life Sciences Solutions Canada Ulc MODIFIED sgRNAs, LIPID NANOPARTICLES WITH MODIFIED sgRNAs, AND USES THEREOF
WO2026153956A1 (en) 2025-01-14 2026-07-23 Global Life Sciences Solutions Canada Ulc Stabilizing agents, compositions, and uses thereof
WO2026159142A1 (en) 2025-01-22 2026-07-30 Global Life Sciences Solutions Canada Ulc Lipid nanoparticles comprising sugar-based stabilizing agents for nucleic acid delivery and method of preparation thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0854716A (ja) 1994-08-12 1996-02-27 Konica Corp ハロゲン化銀写真感光材料およびその処理方法
US5753613A (en) 1994-09-30 1998-05-19 Inex Pharmaceuticals Corporation Compositions for the introduction of polyanionic materials into cells
US6734171B1 (en) 1997-10-10 2004-05-11 Inex Pharmaceuticals Corp. Methods for encapsulating nucleic acids in lipid bilayers
EP1412065A2 (en) 2001-07-27 2004-04-28 President And Fellows Of Harvard College Laminar mixing apparatus and methods
JP5300119B2 (ja) 2007-08-28 2013-09-25 Jfeスチール株式会社 シームレス缶用表面処理鋼板、樹脂被覆鋼板及びシームレス缶
EP3100718B1 (en) * 2008-01-02 2019-11-27 Arbutus Biopharma Corporation Improved compositions and methods for the delivery of nucleic acids
EP3699172A3 (en) * 2008-11-10 2020-11-18 Arbutus Biopharma Corporation Novel lipids and compositions for the delivery of therapeutics
KR20220038506A (ko) 2009-06-10 2022-03-28 알닐람 파마슈티칼스 인코포레이티드 향상된 지질 조성물
RU2573409C2 (ru) 2009-11-04 2016-01-20 Дзе Юниверсити Оф Бритиш Коламбиа Содержащие нуклеиновые кислоты липидные частицы и относящиеся к ним способы
US9999673B2 (en) * 2011-01-11 2018-06-19 Alnylam Pharmaceuticals, Inc. PEGylated lipids and their use for drug delivery
TW201309621A (zh) 2011-02-08 2013-03-01 Daiichi Sankyo Co Ltd 新穎脂質
US20140328759A1 (en) 2011-10-25 2014-11-06 The University Of British Columbia Limit size lipid nanoparticles and related methods
US9352042B2 (en) 2012-02-24 2016-05-31 Protiva Biotherapeutics, Inc. Trialkyl cationic lipids and methods of use thereof
CN105143456A (zh) 2013-03-15 2015-12-09 不列颠哥伦比亚大学 用于转染的脂质纳米粒子和相关方法
US9920003B2 (en) * 2014-08-19 2018-03-20 Archer Daniels Midland Company Non-ionic amphiphiles and methods of making the same
WO2017117647A1 (en) 2016-01-06 2017-07-13 The University Of British Columbia Bifurcating mixers and methods of their use and manufacture
US11059039B2 (en) 2016-07-06 2021-07-13 Precision Nanosystems Inc. Smart microfluidic mixing instrument and cartridges
WO2018062413A1 (ja) * 2016-09-28 2018-04-05 協和発酵キリン株式会社 核酸含有脂質ナノ粒子

Similar Documents

Publication Publication Date Title
JP2022537305A5 (enExample)
JP2024546951A5 (enExample)
JP2022551185A5 (enExample)
JP2024546952A5 (enExample)
JP2017522376A5 (enExample)
JP2022505234A5 (enExample)
JP2011509309A5 (enExample)
JP2021522276A5 (enExample)
JP2024542188A5 (enExample)
JP2011513420A5 (enExample)
JPH07165703A (ja) 緑内障及び高眼圧治療用局所眼薬組成物
EP2349242B1 (en) Amino acid salts of prostaglandins
JP2018521052A5 (enExample)
JP6270848B2 (ja) ベータ−クロロシクロペンタンの親水性エステルプロドラッグの使用による角膜中央部肥厚の低下
RU2008108887A (ru) Жидкие составы
JP2009533462A (ja) ブリモニジンおよびチモロールの組成物
JP2023016959A (ja) 眼科用組成物
JP2004517843A5 (enExample)
TW200512184A (en) 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure
JP2024537784A5 (enExample)
MX2025014915A (es) Lipidos que contienen amida
MX2025015196A (es) Amida y éster mixtos que contienen lípidos para usarse en nanopartículas lipídicas
JP2025504430A5 (enExample)
JP2022529309A5 (enExample)
HU207220B (en) Process for producing pharmaceutical composition for diminishing enhanced pressure of the pulmonary circulation